We help turn science into therapies & products into business.
Consulting Network
Cell Therapy Group (CTG) is the consultancy for the commercial side
of the cell therapy and regenerative medicine sector.
of the cell therapy and regenerative medicine sector.
Cell Therapy Group prides itself in an unparalleled breadth of knowledge of the cell therapy and regenmed industries but this certainly does not come from us alone. We have excelled in bringing in the right external team members for different projects as they require - expertise on technical, regulatory, finance, and other matters which are outside our core expertise but fall within the scope of a client's needs.
We have an outstanding roster of internal and external consultants at our disposal with whom we have worked in various capacities.
Additionally, we work with other consultancies specializing in regenerative medicine as client needs and projects dictate that we include their particular expertise and capacity. These have included:
Additionally, we have outstanding access to key opinion leaders, researchers, and executives including clinical, scientific, policy, regulatory, financial, pharmaceutical, manufacturing, investment, biotech, and other global experts who can be brought in on projects as required.
We also have excellent working relationships with service providers in the industry and can provide analysis of, work with, or help identify and mange CMOs, CROs, facility & quality experts, analysts, modeling experts, reimbursement specialists, clinical design specialists, etc.
While we work predominately in and know best the US market, we also have access to consultants and experts in European, Middle East, and Asian markets that can be brought in as needed.
All these leaders and experts are not generalists or even specialists from other sectors but rather people who have worked in or on cell therapy/regenmed projets and understand the critically unique aspects this industry brings to otherwise common commercial issues.
We have an outstanding roster of internal and external consultants at our disposal with whom we have worked in various capacities.
Additionally, we work with other consultancies specializing in regenerative medicine as client needs and projects dictate that we include their particular expertise and capacity. These have included:
- Biologics Consulting Group
- DCi Biotech
- Pharmanet Consulting
- Progenitor Cell Therapy
- RTI Health Solutions
- and others.
Additionally, we have outstanding access to key opinion leaders, researchers, and executives including clinical, scientific, policy, regulatory, financial, pharmaceutical, manufacturing, investment, biotech, and other global experts who can be brought in on projects as required.
We also have excellent working relationships with service providers in the industry and can provide analysis of, work with, or help identify and mange CMOs, CROs, facility & quality experts, analysts, modeling experts, reimbursement specialists, clinical design specialists, etc.
While we work predominately in and know best the US market, we also have access to consultants and experts in European, Middle East, and Asian markets that can be brought in as needed.
All these leaders and experts are not generalists or even specialists from other sectors but rather people who have worked in or on cell therapy/regenmed projets and understand the critically unique aspects this industry brings to otherwise common commercial issues.